VX-478 oral HIV protease inhibitor: VRTX and partner Kissei Pharmaceutical Co. Ltd. began a Phase I trial in Japan in healthy adult volunteers to assess tolerab

Vertex Pharmaceuticals (VRTX), Cambridge, Mass. Product: VX-478 oral HIV protease inhibitor Indication: HIV infection Status: VRTX and partner Kissei Pharmaceutical Co. Ltd. began a Phase I trial in...